We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Anglo Asian Mining Plc | LSE:AAZ | London | Ordinary Share | GB00B0C18177 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.90 | 2.19% | 88.50 | 85.00 | 92.00 | 88.50 | 83.50 | 83.50 | 92,265 | 09:31:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Miscellaneous Metal Ores,nec | 45.86M | -24.24M | -0.2122 | -3.93 | 98.93M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/5/2020 08:42 | apols pogue, it was a bit vague, it flashed across Bloomberg that the Chinese are shunning all forms of public transport as too risky and taking the car to work causing gridlock and an extra 60 minutes of journey time in Beijing I think.... :-),,, but, to me it seems obvious that's what folks will do,, after all your car is like an extension of your home if only you and your family use it, so it's nice and safe virus wise to get to & from work,,,, also, to me, its all very well UKGOV saying use more bikes and walk,,, but, again I feel people will see that as high risk infection-wise,,,, I would not like to be stuck in the middle of a cycle lane with everyone breathing all over me right now... Cheers Wan :-) | wanobi | |
11/5/2020 08:27 | Away from covid Ince has done well the last few trading days | jbe81 | |
11/5/2020 08:26 | SRB - large inverse H&S there KS,,, bodes well :-) Cheers Wan :-) free stock charts from uk.advfn.com | wanobi | |
11/5/2020 08:16 | a US listing would obviously change the dynamics of the valuation and MCAP for the better, right ?? hmm, interesting cmb, Cheers Wan :-) | wanobi | |
11/5/2020 08:14 | This one; (many thanx LB), many thanx cmb, Cheers Wan :-) Interesting posts on Nasdaq/NYSE valuations. I've just noticed on page 26 of our results presentation we have a new joint broker for the USA. Joint Broker (USA) TKDY, New York Tom Lawrence Tom@tkdyadvisors.com www.tkdyadvisors.com 'Helping UK and European emerging growth companies within the Tech, LifeSci and Media sectors with introductions to long term capital in the USA.' Not listed on Avacta website (yet)and not mentioned on any prior releases. | wanobi | |
11/5/2020 08:11 | They don’t give an exact date AFAIAA mf They just “arrive” :) | jbravo2 | |
11/5/2020 08:09 | Is there a date for results yet? | mad foetus | |
11/5/2020 08:07 | Good morning all. Wan,read post No.3153 on the AVCT BB by Loafofbread..Joint Broker appointed in the USA. TKDY New York. The Man from Dell Monte,he says Yessss 😁 | callmebwana | |
11/5/2020 08:02 | TXP - Cheers Wan :-) | wanobi | |
11/5/2020 07:53 | meanwhile in China, total gridlock as everyone uses their car to get to work & not public transport which I feel will be repeated globally... Oil ? hmm, interesting times,,, GLA Cheers Wan :-) | wanobi | |
11/5/2020 07:51 | MF I have to I agree with Brasso ORPH is only doing what it always was built to do and that is to ramp up sales and profits from combining 2 companies in the same sector, clinical trails, but doing complimentary work so providing a opportunity to increase client spend. hVIVO was only added end last year beginning of this so the numbers are not excessive. It will have the for sale sign put up on it very soon as well so an exit is in sight. | pogue | |
11/5/2020 07:50 | Morning, could be some fireworks then on a few shares and mf sums up my own thoughts, I don’t mind playing a bit of Covid bingo, but it’s stick a finger in the air as to who is going to see it through to commerciality and at what profit. Good luck to everyone anyway. | riggerbeautz | |
11/5/2020 07:44 | MF ORPH is up around 30% since the virus outbreak. Hardly comparable to the risk associated with NCYT, ODX and AVCT. | brasso3 | |
11/5/2020 07:44 | I read most reports about gold, i would say 90% are saying gold will rise. Some say it will drop again before it rises. But 100% agree that over time gold will rise. Also 90% say the equity market will drop, but yet it continues to defy gravity and rise. So looking at fundamentals and what is going on with the economy seems to mean nothing. You only have to look at AAZ to see this. Still making money, one of the few paying a divi, costs dropping with oil and making record profits. But the sheep continue to ignore these facts and so does the market. I have learned the hard way over the years not to gamble because sooner or later you will lose, mostly sooner. So i will stick with the sector that is making money. And if you can find a company that is so under valued its best to jump all over it. AAZ is one such company. Great management, record profits,divi payer,length of mine is the only concern but they look to have that under control. | gold finger 1 | |
11/5/2020 07:44 | great post MF, totally agree, it's a race and still a punt in many respects :-) Cheers Wan :-) | wanobi | |
11/5/2020 07:39 | Link works fine for me. | henwii | |
11/5/2020 07:36 | re ALTN Important to note that Q2 average gold price is already a lot higher than Q1. Finally they seem to be moving forward with their monster resource. | brasso3 | |
11/5/2020 07:28 | ALTN - Altyn's production up 130% year on year :-) GLA Holders, Cheers Wan :-) | wanobi | |
11/5/2020 07:23 | ORPH - yep, good news also :-) GLA Holders, cheers Wan :-) "We are delighted to exclusively partner with Quotient Limited to bring fast and accurate COVID-19 antibody testing to the UK. Open Orphan plc, via our subsidiary hVIVO, has industry leading scientific and laboratory capability and the MosaiQ(TM) system's best in class COVID-19 antibody testing performance makes the system a natural addition to our state-of-the-art virology laboratory in London. There is a clear demand for COVID-19 antibody testing and we will be making testing available both as a standalone offering and will also utilize the testing capability to screen volunteers for our industry leading range of human challenge studies to ensure no disruption to our clients." | wanobi | |
11/5/2020 07:22 | Lack of a price on the ORPH RNS is annoying. I am sure Cathal will be getting interviewed about it this week and give an indication though. | pogue | |
11/5/2020 07:21 | 4D - step in the right direction,,, The safety review committee for the study has evaluated data collected during the Dose Limiting Toxicity (DLT) period of the trial, the first cycle of treatment for the first 12 patients. The committee determined that it is safe to proceed to Part B of the study. All good :-) GLA Holders Cheers Wan :-) | wanobi |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions